PT  - JOURNAL ARTICLE
AU  - Barak, Netta
AU  - Ben-Ami, Roni
AU  - Sido, Tal
AU  - Perri, Amir
AU  - Shtoyer, Aviad
AU  - Rivkin, Mila
AU  - Licht, Tamar
AU  - Peretz, Ayelet
AU  - Magenheim, Judith
AU  - Fogel, Irit
AU  - Livneh, Ayala
AU  - Daitch, Yutti
AU  - Oiknine-Djian, Esther
AU  - Benedek, Gil
AU  - Dor, Yuval
AU  - Wolf, Dana G.
AU  - Yassour, Moran
AU  - ,
TI  - Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests
AID  - 10.1101/2020.10.16.20213405
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.16.20213405
4099  - http://medrxiv.org/content/early/2020/10/20/2020.10.16.20213405.short
4100  - http://medrxiv.org/content/early/2020/10/20/2020.10.16.20213405.full
AB  - Pooling multiple swab samples prior to RNA extraction and RT-PCR analysis was proposed as a strategy to reduce costs and increase throughput of SARS-CoV-2 tests. However, reports on practical large-scale group testing for SARS-CoV-2 have been scant. Key open questions concern reduced sensitivity due to sample dilution; the rate of false positives; the actual efficiency (number of tests saved by pooling) and the impact of infection rate in the population on assay performance. Here we report analysis of 133,816 samples collected at April-September 2020, tested by pooling for the presence of SARS-CoV-2. We spared 76% of RNA extraction and RT-PCR tests, despite the reality of frequently changing prevalence rate (0.5%-6%). Surprisingly, we observed pooling efficiency and sensitivity that exceed theoretical predictions, which resulted from non-random distribution of positive samples in pools. Overall, the findings strongly support the use of pooling for efficient large high throughput SARS-CoV-2 testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by The Edmond de Rothschild Foundation (Israel) grant for coronavirus research. Y. Dor is supported by a generous gift from Shlomo Kramer. N. Barak is supported by the Hebrew University Faculty of Medicine Computational Medicine Fellowship. M. Yassour is supported by the Azrieli Faculty Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has received IRB exemption from the Israeli Ministry of Health.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCt values from the pools and individual are available upon request